Education
About Us
Working with TipRanks
Follow Us
Generation Bio Co. (GBIO)
NASDAQ:GBIO
Total Valuation
Generation Bio has a market cap or net worth of $35.36M. The enterprise value is -$34.58M.
Market Cap$35.36M
Enterprise Value-$34.58M
Share Statistics
Generation Bio has 6,735,544 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,735,544
Owned by Insiders17.72%
Owned by Institutions21.87%
Financial Efficiency
Generation Bio’s return on equity (ROE) is -1.53 and return on invested capital (ROIC) is -64.10%.
Return on Equity (ROE)-1.53
Return on Assets (ROA)-0.57
Return on Invested Capital (ROIC)-64.10%
Return on Capital Employed (ROCE)-0.73
Revenue Per Employee172.97K
Profits Per Employee-1.14M
Employee Count115
Asset Turnover0.09
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Generation Bio is ―. Generation Bio’s PEG ratio is -0.81.
PE Ratio―
PS Ratio3.55
PB Ratio0.82
Price to Fair Value0.82
Price to FCF-0.78
Price to Operating Cash Flow-0.43
PEG Ratio-0.81
Income Statement
In the last 12 months, Generation Bio had revenue of 19.89M and earned -131.67M in profits. Earnings per share was -19.76.
Revenue19.89M
Gross Profit-27.88M
Operating Income-142.39M
Pretax Income-131.67M
Net Income-131.67M
EBITDA-74.26M
Earnings Per Share (EPS)-19.76
Cash Flow
In the last 12 months, operating cash flow was -113.65M and capital expenditures -1.08M, giving a free cash flow of -114.73M billion.
Operating Cash Flow-113.65M
Free Cash Flow-114.73M
Free Cash Flow per Share-17.03
Dividends & Yields
Generation Bio pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.28
52-Week Price Change-77.39%
50-Day Moving Average5.95
200-Day Moving Average5.11
Relative Strength Index (RSI)31.19
Average Volume (3m)52.92K
Important Dates
Generation Bio upcoming earnings date is Mar 12, 2026, Before Open (Confirmed).
Last Earnings DateNov 5, 2025
Next Earnings DateMar 12, 2026
Ex-Dividend Date―
Financial Position
Generation Bio as a current ratio of 5.50, with Debt / Equity ratio of 157.71%
Current Ratio5.50
Quick Ratio5.50
Debt to Market Cap0.18
Net Debt to EBITDA-0.23
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Generation Bio has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Generation Bio EV to EBITDA ratio is -1.18, with an EV/FCF ratio of -0.97.
EV to Sales4.42
EV to EBITDA-1.18
EV to Free Cash Flow-0.97
EV to Operating Cash Flow-0.99
Balance Sheet
Generation Bio has $89.62M in cash and marketable securities with $26.10M in debt, giving a net cash position of $63.53M billion.
Cash & Marketable Securities$89.62M
Total Debt$26.10M
Net Cash$63.53M
Net Cash Per Share$9.43
Tangible Book Value Per Share$12.94
Margins
Gross margin is 100.00%, with operating margin of -715.82%, and net profit margin of -661.91%.
Gross Margin100.00%
Operating Margin-715.82%
Pretax Margin-661.91%
Net Profit Margin-661.91%
EBITDA Margin-373.33%
EBIT Margin-398.11%
Analyst Forecast
The average price target for Generation Bio is $11.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$11.00
Price Target Upside119.12% Upside
Analyst ConsensusModerate Buy
Analyst Count6
Revenue Growth Forecast-17.82%
EPS Growth Forecast57.32%